Advancing Arrhythmia Therapy by Bridging the Scales from Molecule to Organ

The Cardiac Arrhythmia Mechanisms GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

Disorders of heart rhythm are leading causes of sudden death and stroke. Recent progress in elucidating molecular, cellular, and systems level mechanisms have promoted new concepts that are inspiring more effective treatment strategies. The 2023 Gordon Research Conference (GRC) on Cardiac Arrhythmia Mechanisms will emphasize the multiscale nature of current challenges in understanding arrhythmia biology, and highlight emerging multidisciplinary investigational and therapeutic approaches in this important field.

The long-term objective of this meeting is to provide a forum for investigators – junior, mid-level and senior – to engage in focused discussion on the latest discoveries in the field of cardiac arrhythmia mechanisms. The meeting fosters the development of trainees by supporting an associated Gordon Research Seminar (GRS) on Cardiac Arrhythmia Mechanisms at which trainees will present their research findings, as well as in a panel discussion with mentors on matters of career pathways and professional development.

Highlights of the 2023 Conference will include emerging technologies relevant to the field; implications of COVID for cardiac electrophysiology and arrhythmia; ionic underpinnings of arrhythmogenesis; and reproducibility, ethics, and transparency in arrhythmia research and therapy.

Approximately 50 speakers/discussion leaders will present cutting-edge work that is mostly unpublished. The program includes current and emerging thought leaders in arrhythmia biology, investigators from complementary scientific disciplines, and many early stage investigators with promising careers. Poster sessions will provide additional opportunity for collegial interactions.